Follow The Filings

DME Capital Management David Einhorn

New York, NY 21 processed 13Fs on this site, 2021 Q3 to 2026 Q3

  • $3.6B
  • 45 holdings
  • 2026 Q3
  • −9.1% QoQ
  • Top 5 37.4%

Portfolio

2026 Q3, filed 11/16/2026, top 12 of 45 holdings

Top 5 37.4%, top 10 52.6%

AUM over time

2026 Q3 $3.6B −9.1% QoQ
2021 Q3: $1.5B 2021 Q3: $1.5B
Q3 2021
2021 Q4: $1.7B, +17.2% QoQ 2021 Q4: $1.7B, +17.2% QoQ
Q4
2022 Q1: $1.6B, −10.0% QoQ 2022 Q1: $1.6B, −10.0% QoQ
Q1 2022
2022 Q2: $1.3B, −18.3% QoQ 2022 Q2: $1.3B, −18.3% QoQ
Q2
2022 Q3: $1.4B, +9.8% QoQ 2022 Q3: $1.4B, +9.8% QoQ
Q3
2022 Q4: $1.4B, +2.3% QoQ 2022 Q4: $1.4B, +2.3% QoQ
Q4
2023 Q1: $1.8B, +27.4% QoQ 2023 Q1: $1.8B, +27.4% QoQ
Q1 2023
2023 Q2: $2.1B, +15.9% QoQ 2023 Q2: $2.1B, +15.9% QoQ
Q2
2023 Q3: $1.8B, −17.4% QoQ 2023 Q3: $1.8B, −17.4% QoQ
Q3
2023 Q4: $2B, +16.3% QoQ 2023 Q4: $2B, +16.3% QoQ
Q4
2024 Q1: $2.2B 2024 Q1: $2.2B
Q1 2024
2024 Q2: $2B, −6.5% QoQ 2024 Q2: $2B, −6.5% QoQ
Q2
2024 Q3: $2.4B, +17.6% QoQ 2024 Q3: $2.4B, +17.6% QoQ
Q3
2024 Q4: $1.9B, −19.1% QoQ 2024 Q4: $1.9B, −19.1% QoQ
Q4
2025 Q1: $2B, +1.5% QoQ 2025 Q1: $2B, +1.5% QoQ
Q1 2025
2025 Q2: $2.3B, +17.8% QoQ 2025 Q2: $2.3B, +17.8% QoQ
Q2
2025 Q3: $2.5B, +9.3% QoQ 2025 Q3: $2.5B, +9.3% QoQ
Q3
2025 Q4: $2.8B, +12.1% QoQ 2025 Q4: $2.8B, +12.1% QoQ
Q4
2026 Q1: $3.2B, +12.0% QoQ 2026 Q1: $3.2B, +12.0% QoQ
Q1 2026
2026 Q2: $3.9B, +22.5% QoQ 2026 Q2: $3.9B, +22.5% QoQ
Q2
2026 Q3: $3.6B, −9.1% QoQ 2026 Q3: $3.6B, −9.1% QoQ
Q3

Book

2023 Q1 2022 Q4, filed 15 May, long equity only

GRBK, Green Brick Partners 31.64% Reduce −1.8% 16,600,508 $35.06 $582M −309,453 +$172M
CEIX, Consol Energy 8.60%, was 8.16% Add +49.9% 2,716,741 $58.27 $158M +904,190 +$40M
BHF, Brighthouse Financial 7.49%, was 11.34% Reduce −2.3% 3,122,743 $44.11 $138M −72,907 −$26M
KD, Kyndryl 6.82%, was 6.93% Reduce −5.6% 8,498,845 $14.76 $125M −507,715 +$25M
TECK, Teck Resources 4.94% Add +11.4% 2,491,218 $36.50 $91M +254,700 +$6.3M
THC, Tenet Healthcare 4.61%, was 2.23% Add +116.6% 1,426,970 $59.42 $85M +768,070 +$53M
ODP 3.99%, was 5.21% Reduce −1.2% 1,632,140 $44.98 $73M −19,300 −$1.8M
GPN, Global Payments 3.43%, was 3.25% Add +26.9% 600,430 $105.24 $63M +127,280 +$16M
CPRI, Capri 3.18% Add +31.6% 1,244,040 $47.00 $58M +298,740 +$4.3M
Black Knight 2.89% New 924,740 $57.56 $53M +924,740 +$53M
LIVN, Livanova 2.45% Add +23.4% 1,034,896 $43.58 $45M +196,496 −$1.5M
Southwestern Energy 2.42%, was 3.64% Reduce −0.8% 8,915,700 $5.00 $45M −76,150 −$8M
GLD, SPDR Gold Shares 2.27% Add +8.8% 227,899 $183.22 $42M +18,358 +$6.2M
WFRD, Weatherford International 1.87%, was 2.06% Reduce −0.7% 579,695 $59.35 $34M −4,030 +$4.7M
SLV, iShares Silver Trust 1.79%, was 2.32% Reduce −2.4% 1,487,380 $22.12 $33M −36,630 −$658K
CIVI, Civitas Resources 1.70%, was 1.85% Reduce −0.7% 458,208 $68.34 $31M −3,190 +$4.6M
PKG, Graphic Packaging 1.48% Hold 1,067,670 $25.49 $27M — —
CNXC, Concentrix 1.37%, was 0.89% Add +116.6% 207,961 $121.55 $25M +111,940 +$12M
GPOR, Gulfport Energy 1.23%, was 0.64% Add +125.5% 283,000 $80.00 $23M +157,500 +$13M
FCNCA, First Citizens Bancshares 1.19% New 22,550 $973.10 $22M +22,550 +$22M
NYCB, New York Community Bancorp 1.12% New 2,279,510 $9.04 $21M +2,279,510 +$21M
GPRO, Gopro 0.71%, was 0.92% Reduce −2.5% 2,597,900 $5.03 $13M −67,240 −$205K
REZI, Resideo Technologies 0.65%, was 1.68% Reduce −55.5% 658,088 $18.28 $12M −819,775 −$12M
Danimer Scientific 0.48%, was 0.28% Add +13.3% 2,550,000 $3.45 $8.8M +300,000 +$4.8M
Rice Acquisition Corporation II 0.42% New 760,000 $10.24 $7.8M +760,000 +$7.8M
LKFT, Galapagos 0.32%, was 0.48% Reduce −2.6% 151,368 $38.64 $5.8M −3,990 −$1M
Waverley Capital Acquis 0.19% Hold 350,000 $10.22 $3.6M — —
Panacea Acquisition Corporation II 0.15% Hold 275,000 $10.22 $2.8M — —
GANX, Gain Therapeutics 0.14% Hold 546,560 $4.82 $2.6M — —
OIH, Vaneck ETF Trust 0.10% New 6,960 $277.13 $1.9M +6,960 +$1.9M
COYA, Coya Therapeutics 0.08% Add +0.1% 392,647 $3.97 $1.6M +203 −$299K
IVZ, Invesco Actvely Mngd Etc Fund 0.07% New 96,990 $14.22 $1.4M +96,990 +$1.4M
FCG, First Trust Exchange-Traded Fund 0.07% New 58,540 $22.52 $1.3M +58,540 +$1.3M
Talis Biomedical 0.06% Hold 2,235,783 $0.4900 $1.1M — —
Neubase Therapeutics 0.03% Hold 2,727,027 $0.1850 $505K — —
NUVB, Nuvation Bio 0.00% Hold 34,995 $1.66 $58K — —

Exits / last held

Gone since 2022 Q4, shown at their last reported size.

Stock % of portfolio Recent activity Shares Reported price* Value Share change $ change
VSXY, Victorias Secret And 1.02% Exit 0 $35.78 $15M −411,071 −$15M
Funko 0.39% Exit 0 $10.91 $5.7M −521,500 −$5.7M
CNX, CNX Resources 0.25% Exit 0 $16.84 $3.6M −216,165 −$3.6M
Finserv Acquisition Corporation II 0.22% Exit 0 $10.03 $3.2M −315,000 −$3.2M
Polestar Automotive Holding UK 0.01% Exit 0 $1.12 $92K −82,100 −$92K
23andme — Exit 0 $2.16 $51K −23,591 −$51K

Weight bar: held both quarters added sold at this quarter’s reported price

* Reported price is value ÷ shares from the 13F as of period end, not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Share change and $ change are vs 2022 Q4. Click a column header to sort, or New, Hold, Add or Reduce to bring those moves to the top. Exit opens the last-held block below.

Filings history

21 periods, with AUM normalized

Period Holds AUM QoQ Form Filed Filing ID
2026 Q3 45 $3.6B −9.1% 13F-HR 11/16/2026 000117266126005372
2026 Q2 46 $3.9B +22.5% 13F-HR 8/14/2026 000117266126003786
2026 Q1 45 $3.2B +12.0% 13F-HR 5/15/2026 000117266126002341
2025 Q4 41 $2.8B +12.1% 13F-HR 2/17/2026 000117266126001122
2025 Q3 37 $2.5B +9.3% 13F-HR 11/14/2025 000117266125005032
2025 Q2 34 $2.3B +17.8% 13F-HR 8/14/2025 000117266125003351
2025 Q1 33 $2B +1.5% 13F-HR 5/15/2025 000117266125002307
2024 Q4 36 $1.9B −19.1% 13F-HR 2/14/2025 000117266125001165
2024 Q3 38 $2.4B +17.6% 13F-HR 11/14/2024 000117266124005240
2024 Q2 39 $2B −6.5% 13F-HR 8/14/2024 000117266124003549
2024 Q1 42 $2.2B — 13F-HR 5/15/2024 000117266124002489
2023 Q4 40 $2B +16.3% 13F-HR 2/14/2024 000117266124001512
2023 Q3 39 $1.8B −17.4% 13F-HR 11/14/2023 000117266123004012
2023 Q2 41 $2.1B +15.9% 13F-HR 8/14/2023 000117266123003174
2023 Q1 39 $1.8B +27.4% 13F-HR 5/15/2023 000117266123002282
2022 Q4 42 $1.4B +2.3% 13F-HR 2/14/2023 000117266123001336
2022 Q3 42 $1.4B +9.8% 13F-HR 11/14/2022 000117266122002565
2022 Q2 47 $1.3B −18.3% 13F-HR 8/15/2022 000117266122002019
2022 Q1 52 $1.6B −10.0% 13F-HR 5/16/2022 000117266122001474
2021 Q4 57 $1.7B +17.2% 13F-HR 2/14/2022 000117266122000884
2021 Q3 58 $1.5B — 13F-HR 11/15/2021 000117266121002370

About

DME Capital Management

21 processed 13Fs on this site, 2021 Q3 to 2026 Q3

Entity
DME Capital Management
Notable person
David Einhorn
SEC filing name
DME Capital Management, LP
Location
New York, NY
All SEC filings
View on sec.gov

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

  • The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
  • One Up On Wall Street (Lynch), Peter Lynch View on Amazon

More on the shelf